BN Business News
Add your company to Business Communicator →

Zdrowie i gospodarka · 05/09/2023

FDA to Hold Public Meeting on Reauthorization of Over-the-Counter Monograph Drug User Fee Program

The FDA is seeking public input on proposed recommendations for reauthorizing the program that assesses and collects fees for OTC monograph drugs from FY 2026 to 2030, with a public meeting scheduled to discuss the proposal.

Source: Federal Register — Food and Drug AdministrationOpen original release →